IM ASSOCIATES
0464.554.477 · rovalta.com · 24/09/2026
IM ASSOCIATES
Overview
What does IM ASSOCIATES do?
IM ASSOCIATES is a Private limited company incorporated in 1998. Its main activity is: Management consultancy activities. Its registered office is in Zaventem. It employs on average 18,5 ETP workers (FTE).
1930 Zaventem · FlandreSee on map
Joint committees (3)
- 100
- 200
- 218
Trend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | 3,1 M € | +29.9% | 2,4 M € | -23.1% | 3,1 M € | +52.4% | 2 M € | +1.2% | 2 M € | +15.6% | 1,7 M € | +19.0% | 1,4 M € | +16.9% | 1,2 M € | +3.1% | 1,2 M € | +30.7% | 920,1 k € | +55.3% | 592,3 k € | +59.6% | 371,2 k € | -20.2% | 465,3 k € | -5.9% | 494,3 k € | -25.3% | 662 k € | -16.2% | 790 k € | -14.3% | 921,8 k € | +34.2% | 686,7 k € | +33.5% | 514,4 k € |
| EBITDA | 1,3 M € | +75.6% | 761,7 k € | -6.9% | 818,5 k € | +27.1% | 643,8 k € | -27.1% | 882,9 k € | +4.6% | 843,7 k € | +14.2% | 738,6 k € | +8.5% | 680,9 k € | +10.5% | 616,2 k € | +19.0% | 517,9 k € | +63.0% | 317,8 k € | +27.2% | 249,8 k € | -18.4% | 306,2 k € | +55.9% | 196,4 k € | -18.8% | 241,7 k € | +11.5% | 216,7 k € | -63.1% | 586,9 k € | +34.2% | 437,3 k € | +26.3% | 346,1 k € |
| Operating result | 1,3 M € | +80.9% | 714,2 k € | +0.8% | 708,3 k € | +55.9% | 454,3 k € | -34.2% | 690,8 k € | +14.3% | 604,5 k € | +30.8% | 462,3 k € | +2.2% | 452,2 k € | +4.6% | 432,4 k € | +12.3% | 385,1 k € | +57.2% | 245 k € | +42.7% | 171,7 k € | -29.0% | 242 k € | +97.3% | 122,6 k € | -35.1% | 189 k € | +38.1% | 136,9 k € | -73.1% | 508,4 k € | +39.7% | 363,9 k € | +11.1% | 327,5 k € |
| Net result | 929,6 k € | +89.0% | 491,8 k € | -0.3% | 493,3 k € | +49.6% | 329,7 k € | -35.1% | 508,1 k € | +29.2% | 393,2 k € | +22.4% | 321,2 k € | +26.0% | 254,9 k € | -0.9% | 257,2 k € | +9.8% | 234,2 k € | +57.9% | 148,3 k € | +46.8% | 101 k € | -29.8% | 143,8 k € | +155% | 56,5 k € | -43.0% | 99,1 k € | +55.7% | 63,7 k € | -79.5% | 311 k € | +39.5% | 222,9 k € | +11.3% | 200,3 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 786,9 k € | -8.2% | 857,3 k € | -0.9% | 865,5 k € | -39.3% | 1,4 M € | +5.9% | 1,3 M € | +29.7% | 1 M € | +22.9% | 843,8 k € | +17.1% | 720,3 k € | +6.9% | 673,9 k € | +7.8% | 625,2 k € | +4.3% | 599,6 k € | +2.3% | 586,3 k € | +1.9% | 575,3 k € | +4.3% | 551,5 k € | +1.2% | 545 k € | +1.7% | 535,9 k € | +6.7% | 502,3 k € | +25.2% | 401,3 k € | +34.5% | 298,4 k € |
| Total assets | 2,6 M € | +14.5% | 2,3 M € | +5.6% | 2,2 M € | -45.8% | 4 M € | +7.5% | 3,7 M € | +30.0% | 2,8 M € | -11.7% | 3,2 M € | +3.1% | 3,1 M € | +7.3% | 2,9 M € | +38.1% | 2,1 M € | +54.3% | 1,4 M € | +13.1% | 1,2 M € | -10.2% | 1,3 M € | +8.4% | 1,2 M € | -7.2% | 1,3 M € | +0.5% | 1,3 M € | -4.2% | 1,4 M € | +41.3% | 980,9 k € | +35.2% | 725,5 k € |
| Cash | 531,2 k € | -10.3% | 592,3 k € | +29.9% | 456 k € | -10.5% | 509,3 k € | -32.1% | 750,4 k € | +50.4% | 499 k € | +192% | 171 k € | -70.1% | 571,4 k € | +76.7% | 323,3 k € | -41.4% | 552,1 k € | +71.7% | 321,5 k € | +31.3% | 244,8 k € | -39.1% | 401,8 k € | +98.0% | 202,9 k € | -11.5% | 229,2 k € | +4.4% | 219,6 k € | -43.1% | 385,7 k € | +256% | 108,3 k € | -25.6% | 145,6 k € |
| Debts | 1,8 M € | +59.9% | 1,1 M € | +4.8% | 1,1 M € | -57.0% | 2,5 M € | +11.9% | 2,2 M € | +38.8% | 1,6 M € | -23.9% | 2,1 M € | -3.7% | 2,2 M € | +7.5% | 2 M € | +74.6% | 1,2 M € | +63.3% | 711,2 k € | +24.1% | 573,3 k € | -17.9% | 698 k € | +4.9% | 665,1 k € | -14.8% | 780,9 k € | -0.7% | 786,1 k € | -10.9% | 882 k € | +52.6% | 577,8 k € | +36.2% | 424,2 k € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | 18,5 ETP | -3.1% | 19,1 ETP | +1.6% | 18,8 ETP | +4.4% | 18,0 ETP | +11.8% | 16,1 ETP | +38.8% | 11,6 ETP | +6.4% | 10,9 ETP | +28.2% | 8,5 ETP | -7.6% | 9,2 ETP | +67.3% | 5,5 ETP | +19.6% | 4,6 ETP | +142% | 1,9 ETP | -34.5% | 2,9 ETP | -25.6% | 3,9 ETP | -30.4% | 5,6 ETP | -22.2% | 7,2 ETP | +26.3% | 5,7 ETP | +7.5% | 5,3 ETP | +71.0% | 3,1 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 14 ended
Other companies at this address
| Company | CBE no. |
|---|---|
FORCEA● Active | 0883.520.342 |
IQVIA Cancer Research● Active | 0763.914.095 |
| 0459.151.577 | |
IQVIA Solutions Belgium● Active | 0400.502.211 |
Orifarm Healthcare● Active | 0755.731.948 |
REDPHARMA● Active | 0824.819.011 |
TAKEDA BELGIUM● Active | 0403.054.202 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 18 months | 12 months | 12 months | 12 months |
| Filing date | 13/07/2026 | 23/07/2025 | 19/07/2024 | 18/11/2022 | 26/10/2021 | 16/10/2020 |
| General meeting | 10/07/2026 | 09/07/2025 | 10/07/2024 | 24/10/2022 | 04/10/2021 | 05/10/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 10/07/2026 | 13/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 09/07/2025 | 23/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 10/07/2024 | 19/07/2024 | Dutch | |
| Abridged model | 30/06/2022 | 24/10/2022 | 18/11/2022 | Dutch | |
| Abridged model | 30/06/2021 | 04/10/2021 | 26/10/2021 | Dutch | |
| Abridged model | 30/06/2020 | 05/10/2020 | 16/10/2020 | Dutch | |
| Abridged model | 30/06/2019 | 07/10/2019 | 09/04/2020 | Dutch | |
| Abridged model | 30/06/2018 | 01/10/2018 | 21/12/2018 | Dutch | |
| Abridged model | 30/06/2017 | 02/10/2017 | 29/12/2017 | Dutch | |
| Abridged model | 30/06/2016 | 05/10/2016 | 04/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 05/10/2015 | 29/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 06/10/2014 | 07/10/2014 | Dutch | |
| Abridged model | 30/06/2013 | 07/10/2013 | 05/11/2013 | Dutch | |
| Abridged model | 30/06/2012 | 01/10/2012 | 08/11/2012 | Dutch | |
| Abridged model | 30/06/2011 | 03/10/2011 | 11/10/2011 | Dutch | |
| Abridged model | 30/06/2010 | 04/10/2010 | 28/10/2010 | Dutch | |
| Abridged model | 30/06/2009 | 05/10/2009 | 06/10/2009 | Dutch | |
| Abridged model | 30/06/2008 | 06/10/2008 | 10/10/2008 | Dutch | |
| Abridged model | 30/06/2007 | 08/10/2007 | 24/10/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 14 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates01/09/2026Herbenoeming van de commissaris
- Registered office17/04/2025MAATSCHAPPELIJKE ZETEL
- Other03/07/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - ALGEMENE VERGADERING - BOEKJAAR
- Capital / shares17/04/2023KAPITAAL - AANDELEN
- Restructuring23/03/2023KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates16/03/2023ONTSLAGEN - BENOEMINGEN
- Restructuring19/01/2023RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates23/10/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025929,6 k €↑
- 2024Annual accounts 2024491,8 k €↓
- 2023Annual accounts 2023493,3 k €↑
- 2022Annual accounts 2022329,7 k €↓
- 2021Annual accounts 2021508,1 k €↑
- 2020Annual accounts 2020393,2 k €↑
- 2019Annual accounts 2019321,2 k €↑
- 2018Annual accounts 2018254,9 k €↓
- 2017Annual accounts 2017257,2 k €↑
- 2016Annual accounts 2016234,2 k €↑
- 2015Annual accounts 2015148,3 k €↑
- 2014Annual accounts 2014101 k €↓
- 2013Annual accounts 2013143,8 k €↑
- 2012Annual accounts 201256,5 k €↓
- 2011Annual accounts 201199,1 k €↑
- 2010Annual accounts 201063,7 k €↓
- 2009Annual accounts 2009311 k €↑
- 2008Annual accounts 2008222,9 k €↑
- 2007Annual accounts 2007200,3 k €
- 09/11/1998IncorporationPrivate limited company